Literature DB >> 15078744

Viral community-acquired pneumonia in nonimmunocompromised adults.

Andrés de Roux1, Maria A Marcos, Elisa Garcia, Jose Mensa, Santiago Ewig, Hartmut Lode, Antoni Torres.   

Abstract

INTRODUCTION: Viral community-acquired pneumonia (CAP) has been poorly studied and clinically characterized. Using strict criteria for inclusion, we studied this type of infection in a large series of hospitalized adults with CAP.
MATERIALS AND METHODS: All nonimmunocompromised adult patients with a diagnosis of CAP having paired serology for respiratory viruses (RVs) [338 patients] were prospectively included in the study from 1996 to 2001 at our 1,000-bed university teaching hospital, and subsequently were followed up. We compared patients with pure viral (PV), mixed viral (RV + bacteria), and pneumococcal CAP. RVs (ie, influenza, parainfluenza, respiratory syncytial virus, and adenovirus) were diagnosed by means of paired serology.
RESULTS: Sixty-one of 338 patients (18%) with paired serology had an RV detected, and in 31 cases (9%) it was the only pathogen identified. Influenza was the most frequent virus detected (39 patients; 64%). Patients with chronic heart failure (CHF) had an increased risk of acquiring PV CAP (8 of 26 patients; 31%) when compared to a mixed viral/bacterial etiology (2 of 26 patients; 8%; p = 0.035) or CAP caused by Streptococcus pneumoniae (1 of 44 patients; 2%; p = 0.001). Multivariate analysis revealed that CHF (odds ratio [OR], 15.3; 95% confidence interval [CI], 1.4 to 163; p = 0.024) and the absence of expectoration (OR, 0.14; 95% CI, 0.04 to 0.6; p = 0.006) were associated with PV pneumonia compared to pneumococcal CAP.
CONCLUSION: RVs are frequent etiologies of CAP (single or in combination with bacteria). Patients with CHF have an increased risk of acquiring a viral CAP.

Entities:  

Mesh:

Year:  2004        PMID: 15078744     DOI: 10.1378/chest.125.4.1343

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  59 in total

1.  Viral community-acquired pneumonia: if we do not diagnose it and do not treat it, can it still hurt us?

Authors:  Michael S Niederman
Journal:  Chest       Date:  2010-10       Impact factor: 9.410

2.  The use of antimicrobial agents after diagnosis of viral respiratory tract infections in hospitalized adults: antibiotics or anxiolytics?

Authors:  Kevin T Shiley; Ebbing Lautenbach; Ingi Lee
Journal:  Infect Control Hosp Epidemiol       Date:  2010-11       Impact factor: 3.254

3.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

4.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

Review 5.  Influenza.

Authors:  John H Beigel
Journal:  Crit Care Med       Date:  2008-09       Impact factor: 7.598

6.  Epidemiology and predictors of multidrug-resistant community-acquired and health care-associated pneumonia.

Authors:  Alan E Gross; Trevor C Van Schooneveld; Keith M Olsen; Mark E Rupp; Thu Hong Bui; Elsie Forsung; Andre C Kalil
Journal:  Antimicrob Agents Chemother       Date:  2014-06-23       Impact factor: 5.191

7.  Optimal Timing of Repeat Multiplex Molecular Testing for Respiratory Viruses.

Authors:  Yamini Mandelia; Gary W Procop; Sandra S Richter; Sarah Worley; Wei Liu; Frank Esper
Journal:  J Clin Microbiol       Date:  2020-01-28       Impact factor: 5.948

Review 8.  The diagnosis of viral respiratory disease in older adults.

Authors:  H Keipp Talbot; Ann R Falsey
Journal:  Clin Infect Dis       Date:  2010-03-01       Impact factor: 9.079

Review 9.  Value of RVP in clinical settings: intensive care.

Authors:  Tony Mazzulli
Journal:  J Clin Virol       Date:  2007-11       Impact factor: 3.168

Review 10.  Low zinc status: a new risk factor for pneumonia in the elderly?

Authors:  Junaidah B Barnett; Davidson H Hamer; Simin N Meydani
Journal:  Nutr Rev       Date:  2010-01       Impact factor: 7.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.